Cabaletta Bio (NASDAQ:CABA) PT Lowered to $25.00
Cabaletta Bio (NASDAQ:CABA – Get Free Report) had its target price decreased by investment analysts at HC Wainwright from $30.00 to $25.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Other equities research analysts also recently issued reports about the stock. Stifel Nicolaus reiterated […]
More Stories
Tekkorp Digital Acquisition (OTCMKTS:TEKKU) Trading Down 0.1% – Here’s Why
Tekkorp Digital Acquisition Corp. (OTCMKTS:TEKKU – Get Free Report)’s share price was down 0.1% during trading on Monday . The...
TZP Strategies Acquisition (OTCMKTS:TZPSU) Trading Up 0.1% – Should You Buy?
Shares of TZP Strategies Acquisition Corp. (OTCMKTS:TZPSU – Get Free Report) shot up 0.1% during mid-day trading on Monday ....
Vickers Vantage Corp. I (OTCMKTS:VCKAU) Stock Price Down 6.9% – Here’s What Happened
Vickers Vantage Corp. I (OTCMKTS:VCKAU – Get Free Report) fell 6.9% during trading on Monday . The company traded as...
Flughafen Zürich (OTCMKTS:FLGZY) Shares Down 0.9% – Should You Sell?
Flughafen Zürich AG (OTCMKTS:FLGZY – Get Free Report)’s share price traded down 0.9% during mid-day trading on Monday . The...
Direxion World Without Waste ETF (NYSEARCA:WWOW) Stock Price Down 2.3% – Here’s Why
Direxion World Without Waste ETF (NYSEARCA:WWOW – Get Free Report) dropped 2.3% during trading on Monday . The stock traded...
LAVA Therapeutics (NASDAQ:LVTX) Stock Price Up 5.1% – Should You Buy?
LAVA Therapeutics N.V. (NASDAQ:LVTX – Get Free Report)’s stock price shot up 5.1% on Monday . The company traded as...